Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18893
Abstract: Dear Editor, We read with interest the article by Baffa et al., who reported a case of severe bullous pemphigoid (BP) developed 10 days after the second dose of Pfizer/BioNtech BNT162b2 mRNA vaccine against Covid19,…
read more here.
Keywords:
rituximab successfully;
bullous pemphigoid;
treated dupilumab;
severe bullous ... See more keywords